|
CN111732549A
|
|
Preparation process of lorazepam impurity C
|
|
CN111777563A
|
|
Preparation process of oxazepam impurity II
|
|
CN110878101A
|
|
Novel method for preparing cefixime mother nucleus 7-AMOCA
|
|
CN110950792A
|
|
Improved preparation method of captopril
|
|
CN110790714A
|
|
Preparation process of lorazepam impurity D
|
|
CN110804023A
|
|
Lorazepam purification method
|
|
CN110804640A
|
|
Production fermentation process of hydrocortisone
|
|
CN110862431A
|
|
Preparation method of high-quality prednisone acetate and intermediate thereof
|
|
CN110862430A
|
|
Preparation method of 5 α -androstane-3, 17-dione
|
|
CN110862382A
|
|
Improved preparation method of ticagrelor intermediate
|
|
CN110563787A
|
|
preparation method of 5 alpha-androstane-17-hydroxy-3-ketone
|
|
CN110563788A
|
|
preparation method of 5 alpha-androstane-3, 17-dione
|
|
CN109503561A
|
|
A kind of preparation method of thiamine tetrahydrofuryl disfulfide
|
|
CN109438335A
|
|
A kind of refining methd of Inositol Nicotinate
|
|
CN109528668A
|
|
Acetylsalicylic acid tablet and preparation method thereof
|
|
CN109771383A
|
|
Vitamin B compound particle, vitamin B complex tablet and preparation method thereof
|
|
CN109400567A
|
|
A method of synthesis glycyrrhizin
|
|
CN109503692A
|
|
A kind of synthetic method of -17 beta-hydroxy -3- ketone of -17 Alpha-Methyl of androstane
|
|
CN109438538A
|
|
A kind of synthetic method of -17 beta-hydroxy -3- ketone of -17 Alpha-Methyl of Stanozolol intermediate androstane
|
|
CN109503691A
|
|
A kind of synthetic method of 5 α-androstane -3,17- diketone
|
